Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Considering the years of retirement is essential for effective financial planning. Evaluate your needs and prepare for a comfortable future.
21,046 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
Iranian strikes have sharply reduced Qatar's LNG output, cutting roughly 17% of capacity and threatening global suppl...
NVIDIA led the AI chip boom, but growing competition and supply forces may erode its edge. This guide breaks down the...
As Berkshire Hathaway's leadership evolves, investors wonder if berkshire hathaway greg abel has echoed Warren Buffet...
Big Tech’s AI investments are driving a potential $700B spend this year. This guide breaks down who wins, how to inve...
The AI era hinges on faster data movement and scalable hardware. This article explains why optical networking could b...
Could SpaceX stock reach $192 by 2027? This guide lays out the drivers, the math behind the target, and realistic ste...
Netflix has fallen sharply, but a trough like this can hide opportunity. This guide breaks down what drove the declin...
Nvidia dominates today’s AI data centers, but the real threat to its throne may be a risk that sits in plain sight. T...
A large new study finds boosted homework scores when AI is used for assignments, yet exam results and college admissi...
Investors rotated into AI infrastructure plays this week, lifting Argan and similar names. This piece breaks down the...